Search

Your search keyword '"Windsor, Joseph"' showing total 11 results
Start Over Author "Windsor, Joseph" Journal american journal of gastroenterology
11 results on '"Windsor, Joseph"'

1. S1099 Comparison of Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Between Smokers and Non-Smokers

Author

Ernest-Suarez, Kenneth, primary, Quan, Joshua, additional, Yeaman, Fiona, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Rowan, Catherine, additional, Hracs, Lindsay, additional, Sharifi, Nastaran, additional, Herauf, Michelle, additional, Markovinović, Ante, additional, Coward, Stephanie, additional, Windsor, Joseph W., additional, Caplan, Léa, additional, Ingram, Richard J. M., additional, Seow, Cynthia, additional, Novak, Kerri, additional, Lu, Cathy, additional, and Kaplan, Gilaad G., additional

Published
2023
Full Text
View/download PDF

2. S1100 Associations Between Body Mass Index and Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease

Author

Ernest-Suarez, Kenneth, primary, Yeaman, Fiona, additional, Quan, Joshua, additional, Rowan, Catherine, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Hracs, Lindsay, additional, Sharifi, Nastaran, additional, Herauf, Michelle, additional, Markovinović, Ante, additional, Coward, Stephanie, additional, Windsor, Joseph W., additional, Caplan, Léa, additional, Ingram, Richard J. M., additional, Seow, Cynthia, additional, Novak, Kerri, additional, Lu, Cathy, additional, and Kaplan, Gilaad G., additional

Published
2023
Full Text
View/download PDF

3. S1098 Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Are Impaired for Those on Anti-TNF and Immunomodulator Combination Therapy

Author

Ernest-Suarez, Kenneth, primary, Rowan, Catherine, additional, Quan, Joshua, additional, Yeaman, Fiona, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Hracs, Lindsay, additional, Sharifi, Nastaran, additional, Herauf, Michelle, additional, Markovinović, Ante, additional, Coward, Stephanie, additional, Windsor, Joseph W., additional, Caplan, Léa, additional, Ingram, Richard J. M., additional, Seow, Cynthia, additional, Novak, Kerri, additional, Lu, Cathy, additional, and Kaplan, Gilaad G., additional

Published
2023
Full Text
View/download PDF

4. Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease

Author

Markovinović, Ante, primary, Quan, Joshua, additional, Herauf, Michelle, additional, Hracs, Lindsay, additional, Windsor, Joseph W., additional, Sharifi, Nastaran, additional, Coward, Stephanie, additional, Caplan, Léa, additional, Gorospe, Julia, additional, Ernest-Suarez, Kenneth, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Ingram, Richard J. M., additional, Kanji, Jamil N., additional, Tipples, Graham, additional, Holodinsky, Jessalyn K., additional, Bernstein, Charles N., additional, Mahoney, Douglas J., additional, Bernatsky, Sasha, additional, Benchimol, Eric I., additional, and Kaplan, Gilaad G., additional

Published
2023
Full Text
View/download PDF

5. S1004 Adverse Events and Serological Responses Following SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease

Author

Markovinovic, Ante, primary, Herauf, Michelle, additional, Quan, Joshua, additional, Hracs, Lindsay, additional, Windsor, Joseph, additional, Sharifi, Nastaran, additional, Coward, Stephanie, additional, Caplan, Léa, additional, Ma, Christopher, additional, Panaccione, Remo, additional, Ingram, Richard, additional, Kanji, Jamil, additional, Tipples, Graham, additional, Holodinsky, Jessalyn, additional, Bernstein, Charles, additional, Mahoney, Douglas, additional, Bernatsky, Sasha, additional, Benchimol, Eric, additional, and Kaplan, Gilaad, additional

Published
2022
Full Text
View/download PDF

6. The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)

Author

Azhari, Hassan, primary, King, James A., additional, Coward, Stephanie, additional, Windsor, Joseph W., additional, Ma, Christopher, additional, Shah, Shailja C., additional, Ng, Siew C., additional, Mak, Joyce W.Y., additional, Kotze, Paulo G., additional, Ben-Horin, Shomron, additional, Loftus, Edward V., additional, Lees, Charlie W., additional, Gearry, Richard, additional, Burisch, Johan, additional, Lakatos, Peter L., additional, Calvet, Xavier, additional, Bosques Padilla, Francisco Javier, additional, Underwood, Fox E., additional, and Kaplan, Gilaad G., additional

Published
2022
Full Text
View/download PDF

9. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis

Author

King, James A., primary, Jeong, Jocelyn, additional, Underwood, Fox E., additional, Quan, Joshua, additional, Panaccione, Nicola, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, deBruyn, Jennifer, additional, Ronksley, Paul E., additional, Shaheen, Abdel-Aziz, additional, Quan, Hude, additional, Godley, Jenny, additional, Veldhuyzen van Zanten, Sander, additional, Lebwohl, Benjamin, additional, Ng, Siew C., additional, Ludvigsson, Jonas F., additional, and Kaplan, Gilaad G., additional

Published
2020
Full Text
View/download PDF

10. Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis.

Author

Coward S, Benchimol EI, Bernstein CN, Avina-Zubieta A, Bitton A, Carroll MW, Cui Y, Hoentjen F, Hracs L, Jacobson K, Jones JL, King J, Kuenzig ME, Lu N, El-Matary W, Murthy SK, Nugent Z, Otley AR, Panaccione R, Peña-Sánchez JN, Singh H, Targownik LE, White D, Windsor JW, and Kaplan GG

Subjects
Humans, Incidence, Prevalence, Canada epidemiology, Adolescent, Adult, Female, Male, Middle Aged, Young Adult, Child, Aged, Age Distribution, Child, Preschool, Forecasting, Inflammatory Bowel Diseases epidemiology
Abstract

Introduction: Canada has a high burden of inflammatory bowel disease (IBD). Historical trends of IBD incidence and prevalence were analyzed to forecast the Canadian burden over the next decade., Methods: Population-based surveillance cohorts in 8 provinces derived from health administrative data assessed the national incidence (2007-2014) and prevalence (2002-2014) of IBD. Autoregressive integrated moving average models were used to forecast incidence and prevalence, stratified by age, with 95% prediction intervals (PI), to 2035. The average annual percentage change (AAPC) with 95% confidence interval (CI) was calculated for the forecasted incidence and prevalence., Results: The national incidence of IBD is estimated to be 29.9 per 100,000 (95% PI 28.3-31.5) in 2023. With a stable AAPC of 0.36% (95% CI -0.05 to 0.72), the incidence of IBD is forecasted to be 31.2 per 100,000 (95% PI 28.1-34.3) in 2035. The incidence in pediatric patients (younger than 18 years) is increasing (AAPC 1.27%; 95% CI 0.82-1.67), but it is stable in adults (AAPC 0.26%; 95% CI -0.42 to 0.82). The prevalence of IBD in Canada was 843 per 100,000 (95% PI 716-735) in 2023 and is expected to steadily climb (AAPC 2.43%; 95% CI 2.32-2.54) to 1,098 per 100,000 (95% PI 1,068-1,127) by 2035. The highest prevalence is in seniors with IBD (1,174 per 100,000 in 2023; AAPC 2.78%; 95% CI 2.75-2.81)., Discussion: Over the next decade, the Canadian health care systems will contend with the juxtaposition of rising incidence of pediatric IBD and a rising prevalence of overall IBD driven by the aging population., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.)

Published
2024
Full Text
View/download PDF

11. Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease.

Author

Markovinović A, Quan J, Herauf M, Hracs L, Windsor JW, Sharifi N, Coward S, Caplan L, Gorospe J, Ernest-Suarez K, Ma C, Panaccione R, Ingram RJM, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, and Kaplan GG

Subjects
Humans, Antibodies, Viral, Injection Site Reaction, SARS-CoV-2, Vaccination, COVID-19 epidemiology, COVID-19 prevention & control, COVID-19 Vaccines adverse effects, Inflammatory Bowel Diseases
Abstract

Introduction: We determined adverse events after 4 doses of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine in those with inflammatory bowel disease (IBD), associations between antibodies and injection site reactions (ISR), and risk of IBD flare., Methods: Individuals with IBD were interviewed for adverse events to SARS-CoV-2 vaccine. Multivariable linear regression assessed the association between antibody titers and ISR., Results: Severe adverse events occurred in 0.03%. ISR were significantly associated with antibody levels after the fourth dose (geometric mean ratio = 2.56; 95% confidence interval 1.18-5.57). No cases of IBD flare occurred., Discussion: SARS-CoV-2 vaccines are safe for those with IBD. ISR after the fourth dose may indicate increased antibodies., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results